In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Peter Bigelow President at xCell Strategic Consulting.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Peter, covering:
The transition from being on the big pharma sponsor side at Pfizer to being head of one of the world’s biggest CDMOs.
The challenging of adding a development capability to well-oiled manufacturing infrastructure and way of working.
They key buying criteria emerging pharma considers when choose a CDMO.
Increasing consolidation and fragmentation in today’s outsourcing sector due to continued market growth and the explosion of new technologies.

Pete is a very well respect industry leader having spent over 25 years in the global pharmaceutical manufacturing space. He was at Wyeth and then Pfizer for the best part of 15 years before becoming the interim CEO and President of North American operations at Patheon. He since moved into management consulting before establishing his own firm called xCell in 2014.
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.